Kytopen Corp. — Form D
Kytopen Corp. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-20. The offering totals $15.0M, of which $7.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-20
- Form: D
- Accession: 0000929638-25-000827
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $7.1M
- Remaining: $7.9M
- Investors: 13
- Date of first sale: 2025-02-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538793
Issuer
- Name: Kytopen Corp.
- CIK: 0001777277
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 750 MAIN STREET, CAMBRIDGE, MA, 02139-4018
- Phone: 617-299-1688
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Cullen Buie | Director | Cambridge, MA |
| Michael Chiu | Director | Cambridge, MA |
| Paxton Major | Director | Austin, TX |
| Paul Wotton | Director | Cambridge, MA |
| Michael Chiu | Executive Officer | Cambridge, MA |
| Julio Vega | Executive Officer | Cambridge, MA |
| Ann DeWitt | Director | Woburn, MA |
| Bethany Grant | Executive Officer | Cambridge, MA |
| Edward Freedman | Director | Cambridge, MA |
| Theresa Tribble | Director | Cambridge, MA |
| Adam Wieschhaus | Director | Cambridge, MA |
| Paulo Garcia | Director | Cambridge, MA |
| Paulo Garcia | Executive Officer | Cambridge, MA |
| Paulo Garcia | Promoter | Cambridge, MA |
Other filings by this issuer (4)
More